(19)
(11) EP 4 824 802 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24902840.8

(22) Date of filing: 11.12.2024
(51) International Patent Classification (IPC): 
G16B 40/00(2019.01)
(52) Cooperative Patent Classification (CPC):
G16B 40/20; G16B 25/10
(86) International application number:
PCT/CN2024/138382
(87) International publication number:
WO 2025/124420 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.12.2023 WO PCT/CN2023/138363

(71) Applicant: Singleron (Nanjing) Biotechnologies, Ltd.
Nanjing, Jiangsu 211800 (CN)

(72) Inventors:
  • FANG, Nan
    Nanjing, Jiangsu 211800 (CN)
  • ZHU, Wenqi
    Nanjing, Jiangsu 211800 (CN)
  • WEI, Xing
    Nanjing, Jiangsu 211800 (CN)

(74) Representative: Evans, Sophie Elizabeth 
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) LARGE-SCALE DRUG SCREENING